Health Canada approves submission that could make Pfizer-BioNTech’s COVID-19 vaccine more easily transported
If you're frustrated with the slow pace Canadians have been vaccinated for COVID-19 thus far, there's good news.
Health Canada has announced it has approved a submission from Pfizer-BioNTech, which would allow for easier transportation of the vaccine.
Now, rather than the ultra cold temperature in which the vaccine previously had to be transported, it can be transported at regular freezer temperatures--between -25degC and -15degC.
Additionally, the vials can be stored and transported at this temperature for up to two weeks--it can also be stored once at the previous temperatures--between -80degC to -60degC.
According to Health Canada, a thorough review of Pfizer-BioNTech's submission indicated the vaccine remains stable and effective when stored at regular, freezer temperatures for up to two weeks, meaning it meets Health Canada’s quality standards.
However, despite this, ultra-cold conditions are still recommended for storing and transporting the vaccine.
- Health Canada agrees Pfizer-BioNTech vaccine vials have six doses
- Health Canada approves Pfizer’s COVID-19 vaccine
- First doses of Pfizer COVID-19 vaccine, not yet approved, to land in Canada next week
- Canada to receive record 640K vaccine doses this week with Pfizer, Moderna deliveries
- Pfizer COVID-19 vaccine allocations to Canada already assuming six doses per vial
- Brampton truck driver charged for smuggling cocaine into Canada
- Alarmingly 20% of all Brampton being tested currently have COVID-19
- Mississauga boxing gym defying provincial lockdown orders facing charges by City
- Peel's Chief Medical Officer of Health chats about COVID-19 and vaccinations for Mississauga and Brampton- April 14, 2021
- 65% of all Mississauga and Brampton residents will have a vaccine shot by June